Glioblastoma (GBM) is the most common primary brain tumor in adults and often has
amplification of the epidermal growth factor receptor (EGFR) gene. The value of EGFR as a …

Amplification of the epidermal growth factor receptor (EGFR) gene occurs in approximately
40% of cases of glioblastoma multiforme (GBM) and is considered a possible marker of poor …

Despite the high incidence of EGFR amplification in patient glioblastoma multiforme (GBM)
tissues, only a single GBM cell line, of the many described in the literature, is known to …

Background The epidermal growth factor receptor (EGFR) is over expressed in
approximately 50–60% of glioblastoma (GBM) tumors, and the most common EGFR mutant …

Glioblastoma multiforme (GBM) frequently involves amplification and alteration of the
epidermal growth factor receptor (EGFR) gene, resulting in overexpression of varied …

Purpose: Approximately 40% of all glioblastomas have amplified the EGFR gene, and about
half of these tumors express the EGFRvIII variant. The prognostic role of EGFRvIII in EGFR …

Epidermal growth factor receptor (EGFR) overexpression occurs in a significant percentage
of cases of glioblastoma multiforme (GBM), and amplification has been found in …

Objectives Epidermal growth factor receptor (EGFR) gene amplification and the EGFR v III
mutation may have prognostic value in patients with glioblastoma. This meta‐analysis was …

Purpose: There have been conflicting reports in the literature regarding the prognostic
significance of epidermal growth factor receptor (EGFR) amplification in patients with …

Epidermal growth factor receptor (EGFR) is produced during the molecular pathogenesis of
glioma, and new anti-EGFR molecules are available for therapeutics. Consequently …